278 related articles for article (PubMed ID: 20086232)
1. Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.
Conti R; Veenstra DL; Armstrong K; Lesko LJ; Grosse SD
Med Decis Making; 2010; 30(3):328-40. PubMed ID: 20086232
[TBL] [Abstract][Full Text] [Related]
2. Translating genomics in cancer care.
Bombard Y; Bach PB; Offit K
J Natl Compr Canc Netw; 2013 Nov; 11(11):1343-53. PubMed ID: 24225968
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness, personalized medicine and innovation: the path forward.
Thomas A; Phillips A; Donnelly R; Piech CT
Pharmacoeconomics; 2010; 28(10):923-30. PubMed ID: 20831300
[No Abstract] [Full Text] [Related]
4. Toward clinical genomics in everyday medicine: perspectives and recommendations.
Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
[TBL] [Abstract][Full Text] [Related]
5. Public Funding for Genomics and the Return on Investment: A Public Health Perspective.
Hyder A
Perspect Biol Med; 2018; 61(4):572-583. PubMed ID: 30613039
[TBL] [Abstract][Full Text] [Related]
6. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
Bombard Y
Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
[No Abstract] [Full Text] [Related]
7. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Zaiou M; El Amri H
Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
[TBL] [Abstract][Full Text] [Related]
8. Genomic medicine: health care issues and the unresolved ethical and social dilemmas.
Idemyor V
Am J Ther; 2014; 21(6):548-53. PubMed ID: 22713532
[TBL] [Abstract][Full Text] [Related]
9. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
Swanson KM; Zhu Y; Rojas RL; St Sauver JL; Bielinski SJ; Jacobsen DJ; Visscher SL; Wang L; Weinshilboum R; Borah BJ
PLoS One; 2020; 15(5):e0233316. PubMed ID: 32428022
[TBL] [Abstract][Full Text] [Related]
10. A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.
Meckley LM; Gudgeon JM; Anderson JL; Williams MS; Veenstra DL
Pharmacoeconomics; 2010; 28(1):61-74. PubMed ID: 20014877
[TBL] [Abstract][Full Text] [Related]
11. Personalized genomic information: preparing for the future of genetic medicine.
Guttmacher AE; McGuire AL; Ponder B; Stefánsson K
Nat Rev Genet; 2010 Feb; 11(2):161-5. PubMed ID: 20065954
[TBL] [Abstract][Full Text] [Related]
12. [Genomics and personalized medicine].
Mooser V
Praxis (Bern 1994); 2014 May; 103(10):567-71. PubMed ID: 24800768
[TBL] [Abstract][Full Text] [Related]
13. Personalized medicine in the care of the child with congenital heart disease: discovery to application.
Binesh Marvasti T; D'Alessandro LC; Manase D; Papaz T; Mital S
Congenit Heart Dis; 2013; 8(3):266-9. PubMed ID: 23601919
[TBL] [Abstract][Full Text] [Related]
14. Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century.
Iriart JAB
Cad Saude Publica; 2019 Mar; 35(3):e00153118. PubMed ID: 30916181
[TBL] [Abstract][Full Text] [Related]
15. The impact of genomics on the future of medicine and health.
Mattick JS; Dziadek MA; Terrill BN; Kaplan W; Spigelman AD; Bowling FG; Dinger ME
Med J Aust; 2014 Jul; 201(1):17-20. PubMed ID: 24999876
[No Abstract] [Full Text] [Related]
16. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
[TBL] [Abstract][Full Text] [Related]
17. [Ethical and social issues associated with genomic medicine].
Barazzetti G; Kaufmann A; Benaroyo L
Praxis (Bern 1994); 2014 May; 103(10):573-7. PubMed ID: 24800769
[TBL] [Abstract][Full Text] [Related]
18. Genomic and personalized medicine: foundations and applications.
Ginsburg GS; Willard HF
Transl Res; 2009 Dec; 154(6):277-87. PubMed ID: 19931193
[TBL] [Abstract][Full Text] [Related]
19. Implementing genome-driven personalized cardiology in clinical practice.
Pasipoularides A
J Mol Cell Cardiol; 2018 Feb; 115():142-157. PubMed ID: 29343412
[TBL] [Abstract][Full Text] [Related]
20. Information management to enable personalized medicine: stakeholder roles in building clinical decision support.
Downing GJ; Boyle SN; Brinner KM; Osheroff JA
BMC Med Inform Decis Mak; 2009 Oct; 9():44. PubMed ID: 19814826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
